{"id":7,"date":"2024-04-13T21:33:27","date_gmt":"2024-04-13T21:33:27","guid":{"rendered":"https:\/\/brand2d.tech\/gerties\/?p=7"},"modified":"2024-11-19T10:32:26","modified_gmt":"2024-11-19T07:32:26","slug":"forma-4202-hem-301","status":"publish","type":"post","link":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/","title":{"rendered":"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease"},"content":{"rendered":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text]Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221;&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,20],"tags":[],"class_list":{"0":"post-7","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-case-studies","7":"category-ongoing"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease - Gertrude&#039;s Children Hospital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease - Gertrude&#039;s Children Hospital\" \/>\n<meta property=\"og:description\" content=\"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221;...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\" \/>\n<meta property=\"og:site_name\" content=\"Gertrude&#039;s Children Hospital\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-13T21:33:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T07:32:26+00:00\" \/>\n<meta name=\"author\" content=\"Kevin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\"},\"author\":{\"name\":\"Kevin\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/95fc37f37997584e231526363331b923\"},\"headline\":\"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease\",\"datePublished\":\"2024-04-13T21:33:27+00:00\",\"dateModified\":\"2024-11-19T07:32:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\"},\"wordCount\":197,\"commentCount\":0,\"articleSection\":[\"Case Studies\",\"Ongoing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\",\"url\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\",\"name\":\"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease - Gertrude&#039;s Children Hospital\",\"isPartOf\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/#website\"},\"datePublished\":\"2024-04-13T21:33:27+00:00\",\"dateModified\":\"2024-11-19T07:32:26+00:00\",\"author\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/95fc37f37997584e231526363331b923\"},\"breadcrumb\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brand2d.tech\/gerties\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#website\",\"url\":\"https:\/\/brand2d.tech\/gerties\/\",\"name\":\"Gertrude&#039;s Children Hospital\",\"description\":\"Quality healthcare for children\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brand2d.tech\/gerties\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/95fc37f37997584e231526363331b923\",\"name\":\"Kevin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/18b13200ecfaf6438c282159f8ddd45c3b47fa73167bfcd29cf65085a81ce3a9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/18b13200ecfaf6438c282159f8ddd45c3b47fa73167bfcd29cf65085a81ce3a9?s=96&d=mm&r=g\",\"caption\":\"Kevin\"},\"url\":\"https:\/\/brand2d.tech\/gerties\/author\/kevin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease - Gertrude&#039;s Children Hospital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/","og_locale":"en_US","og_type":"article","og_title":"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease - Gertrude&#039;s Children Hospital","og_description":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221;...","og_url":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/","og_site_name":"Gertrude&#039;s Children Hospital","article_published_time":"2024-04-13T21:33:27+00:00","article_modified_time":"2024-11-19T07:32:26+00:00","author":"Kevin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Kevin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#article","isPartOf":{"@id":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/"},"author":{"name":"Kevin","@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/95fc37f37997584e231526363331b923"},"headline":"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease","datePublished":"2024-04-13T21:33:27+00:00","dateModified":"2024-11-19T07:32:26+00:00","mainEntityOfPage":{"@id":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/"},"wordCount":197,"commentCount":0,"articleSection":["Case Studies","Ongoing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/","url":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/","name":"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease - Gertrude&#039;s Children Hospital","isPartOf":{"@id":"https:\/\/brand2d.tech\/gerties\/#website"},"datePublished":"2024-04-13T21:33:27+00:00","dateModified":"2024-11-19T07:32:26+00:00","author":{"@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/95fc37f37997584e231526363331b923"},"breadcrumb":{"@id":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brand2d.tech\/gerties\/2024\/04\/13\/forma-4202-hem-301\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brand2d.tech\/gerties\/"},{"@type":"ListItem","position":2,"name":"2021 FORMA-4202-HEM-301 \u2013 An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease"}]},{"@type":"WebSite","@id":"https:\/\/brand2d.tech\/gerties\/#website","url":"https:\/\/brand2d.tech\/gerties\/","name":"Gertrude&#039;s Children Hospital","description":"Quality healthcare for children","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brand2d.tech\/gerties\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/95fc37f37997584e231526363331b923","name":"Kevin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/18b13200ecfaf6438c282159f8ddd45c3b47fa73167bfcd29cf65085a81ce3a9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/18b13200ecfaf6438c282159f8ddd45c3b47fa73167bfcd29cf65085a81ce3a9?s=96&d=mm&r=g","caption":"Kevin"},"url":"https:\/\/brand2d.tech\/gerties\/author\/kevin\/"}]}},"_links":{"self":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/posts\/7","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/comments?post=7"}],"version-history":[{"count":0,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/posts\/7\/revisions"}],"wp:attachment":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/media?parent=7"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/categories?post=7"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/tags?post=7"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}